Naturis Cosmetics, a contract manufacturer for beauty brands, is making waves with its maiden funding round. Led by Sharrp Ventures, the company is raising a substantial amount of Rs 33.74 crore ($3.5 million), with participation from Mirabilis Investment Trust. This funding marks a significant milestone for Naturis, which has been a behind-the-scenes player in the beauty industry, supplying products to well-known brands like Nykaa, Plum, Pilgrim, and Bare Anatomy.
What makes this deal particularly intriguing is the valuation. Naturis Cosmetics is estimated to be valued at around Rs 364 crore or approximately $38 million post-money. This valuation is a testament to the company's growth and potential in the B2B contract manufacturing space. With a focus on skincare, haircare, personal care, fragrance, and cosmetics, Naturis is poised to expand its client base and solidify its position in the market.
The funding will be used to further enhance Naturis' capabilities and services. As a contract manufacturer, the company offers end-to-end solutions, including OEM/ODM, private label development, product formulation, R&D, packaging, manufacturing, and regulatory support. This comprehensive approach has likely contributed to its success in attracting major beauty brands as clients.
The involvement of Sharrp Ventures and Mirabilis Investment Trust is notable. Sharrp Ventures, leading the tranche with a significant investment of Rs 22.5 crore, will acquire a 6.19% stake in Naturis Cosmetics. Mirabilis Investment Trust, contributing Rs 11.25 crore, will own a 3.09% stake. These investments signal confidence in Naturis' growth trajectory and its ability to scale its operations.
Naturis Cosmetics' financial performance has been impressive. In FY25, the company reported a 40% year-on-year growth in operating revenue, reaching Rs 154 crore, up from Rs 110 crore in FY24. This growth, coupled with a net profit of Rs 12 crore, showcases Naturis' strong financial health and market competitiveness. The company's ability to maintain profitability while scaling its operations is a positive sign for investors and stakeholders.
Looking ahead, Naturis Cosmetics may have even bigger plans. An earlier report suggested that the company was aiming to raise a larger amount of Rs 80–100 crore. This potential follow-on funding round could further solidify Naturis' position as a leading contract manufacturer in the beauty industry. With its strong financial performance and strategic partnerships, Naturis is well-positioned to capitalize on the growing demand for B2B solutions in the beauty sector.
In conclusion, Naturis Cosmetics' maiden funding round is a significant development in the beauty industry. The company's growth, valuation, and investor confidence highlight its potential to disrupt the market. As Naturis continues to expand its services and client base, it will be fascinating to see how it leverages its newfound financial strength to shape the future of contract manufacturing in the beauty space.
